Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies

Neuroendocrine neoplasia (NEN) comprises heterogeneous tumors that are challenging to diagnose and, especially in cases of poorly differentiated (G3) NEN, are associated with very limited survival. Novel biomarkers allowing an early diagnosis as well as an optimal selection of suitable treatment opt...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of clinical medicine 2020-05, Vol.9 (6), p.1647
Hauptverfasser:	Özdirik, Burcin, Stueven, Anna, Knorr, Jana, Geisler, Lukas, Mohr, Raphael, Demir, Münevver, Hellberg, Teresa, Loosen, Sven H., Benz, Fabian, Wiedenmann, Bertram, Tacke, Frank, Wree, Alexander, Jann, Henning, Roderburg, Christoph
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers Clinical medicine Disease Laboratories Localization Medical prognosis Metabolism Neuroendocrine tumors Patients Small intestine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!